---
title: "UBS maintains Allstate at Neutral, raises price target to $283 from $275"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305063648.md"
description: "UBS maintained its Neutral rating on Allstate while raising its price target from $275 to $283, representing a 2.9% increase. This new target implies an 11.5% upside from the November 9 close of $253.79. The update is part of recent analyst activity, with other firms like Morgan Stanley and Piper Sandler also maintaining their ratings over the past month."
datetime: "2026-11-10T20:39:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305063648.md)
  - [en](https://longbridge.com/en/news/305063648.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305063648.md)
generator: "portal-rs"
---

# UBS maintains Allstate at Neutral, raises price target to $283 from $275

UBS maintained Allstate at Neutral and raised its price target to $283 from $275, a 2.9% increase.

The price target implies an upside of 11.5% from the Nov 9 close of $253.79.

**Recent analyst actions on Allstate**

| Date   | Firm                    | Action    | Rating       | Price target |
| ------ | ----------------------- | --------- | ------------ | ------------ |
| Nov 10 | Morgan Stanley          | Maintains | Equal-Weight | $260         |
| Nov 10 | Keefe, Bruyette & Woods | Maintains | Underperform | $241         |
| Nov 9  | Piper Sandler           | Maintains | Overweight   | $294         |
| Nov 6  | Citigroup               | Maintains | Sell         | $225         |
| Nov 6  | Wells Fargo             | Maintains | Equal-Weight | $252         |

Across the five most recent analyst notes published on Allstate over the past 30 days, price targets range from $225 to $294.

Explore more price target data and ratings for Allstate on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ALL.US](https://longbridge.com/en/quote/ALL.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Morgan Stanley maintains Allstate at Equal-Weight, raises price target to $275 from $260](https://longbridge.com/en/news/305850676.md)
- [Earnings Beat Could Be A Key Test For Allstate Stock (ALL)](https://longbridge.com/en/news/304665082.md)
- [The Allstate Corporation $ALL Shares Sold by Axxcess Wealth Management LLC](https://longbridge.com/en/news/303038652.md)
- [BREAKINGVIEWS-Nine questions for Nvidia’s stand-in CEO](https://longbridge.com/en/news/305850075.md)
- [AI’s 48-Hour Stress Test Starts Now](https://longbridge.com/en/news/305878236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**